For citations:
Ignatova E.O., Frolova M.A., Burdaeva O.N., Nechaeva M.N., Pechenyj A.P., Kopp M.V., Udovitsa D.P., Kotiv B.N., Chubenko V.A., Stroyakovskij D.L., Sheveleva L.P., Khorinko A.V., Prokopenko T.I., Shapovalova Yu.S., Zhevlakova I.A. Results of a multicenter double-blind phase I clinical trial of using of BCD-022 compared with Herceptin, used in combination with paclitaxel in patients with metastatic breast cancer. Malignant tumours. 2014;(4):62-70. (In Russ.) https://doi.org/10.18027/2224-5057-2014-4-62-70